Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Junxi Xu"'
Publikováno v:
New Journal of Physics, Vol 26, Iss 11, p 113009 (2024)
We present a scheme to realize quantum thermal transistor effects in a continuous-variable electromechanical system including two microwave cavities and one mechanical oscillator. The thermal noise fluxes between the quantum system and its baths are
Externí odkaz:
https://doaj.org/article/f923ca2e921a442dacdcb75893634005
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Mammalian cell membranes are decorated by the glycocalyx, which offer versatile means of generating biochemical signals. By manipulating the set of glycans displayed on cell surface, it is vital for gaining insight into the cellular behavior modulati
Externí odkaz:
https://doaj.org/article/cf13178646c3433bb8d99c575bb63fe2
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Maintenance therapy with bevacizumab (Bev) in patients with colorectal cancer (CRC) provides progression-free survival (PFS) benefits. However, the role of maintenance therapy with an anti-EGFR monoclonal antibody has not been established
Externí odkaz:
https://doaj.org/article/610a52cc0ba348cdb7f91dce22bd6b13
Autor:
Jiawei Zhang, Shu Zheng, Dehao Wu, Wen Cai, Xibo Liu, Rui Bai, Haifeng Yu, Weiting Ge, Junxi Xu, Ying Gu, Hanguang Hu, Yanqin Huang
Publikováno v:
Epigenomics. 13:1269-1282
Lay abstract The heterogeneity of colorectal cancer is largely based on their primary tumor locations. For example, patients with left-sided colon cancer generally have better prognoses and different treatment strategies in comparison with patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9841caa159579875b723d7715bb8418
https://doi.org/10.2217/epi-2021-0231
https://doi.org/10.2217/epi-2021-0231
Publikováno v:
International Journal of Medical Sciences
Objective: Malignant rhabdoid tumor (MRT) is a rare but aggressive malignancy. It has been a long time since data on this tumor have been updated. Methods: We retrospectively reviewed patients from the SEER database who were pathologically diagnosed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35f524366b7039aa4f4eebe2097aa595
http://europepmc.org/articles/PMC7807195
http://europepmc.org/articles/PMC7807195
Publikováno v:
Cancer Research. 80:1277-1277
Background: We previously identified SPARC-like 1 (SPARCL1) as a suppressor for colon cancer metastasis. Recent studies confirmed its epigenetic modification in prostate cancer and osteosarcoma. Here we conducted in vivo and in vitro studies to inves
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e579283e75c7aae81b990c287e1ea70
https://doi.org/10.1158/1538-7445.am2020-1277
https://doi.org/10.1158/1538-7445.am2020-1277